David Vocadlo
CSO
BUSINESS MANAGEMENT
Alectos Therapeutics
United States of America
Biography
Dr. David Vocadlo completed his PhD at the University of British Columbia in enzymology and carbohydrate synthesis. Following postdoctoral studies in chemical biology at the University of California at Berkeley, Dr. Vocadlo joined the Department of Chemistry at Simon Fraser University (SFU). Dr. Vocadlo is a Tier I Canada Research Chair in Chemical Biology and a Fellow of the College of New Scholars and Scientists of the Royal Society of Canada. He is a professor in the Departments of Chemistry and Molecular Biology and Biochemistry at SFU. Dr. Vocadlo is a leader in understanding the mechanism of action of carbohydrate processing enzymes and using this information to interrogate these enzymes in biological systems. His research focuses on using a combination of chemical and biological approaches to study carbohydrate structures and to decode their roles in health and disease. Dr. Vocadlo is a co-founder of Alectos and is the Chief Scientific Officer and Chair of the Scientific Advisory Board. He has served on the Board of Directors since founding the company. Dr. Vocadlo has received several awards and is an author of over 100 scientific articles and patents.
Research Interest
BUSINESS MANAGEMENT
